Navigation Links
CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
Date:1/18/2008

KIRKLAND, Wash., Jan. 18 /PRNewswire-FirstCall/ -- In response to the recent comments by certain plaintiff law firms regarding their filing of class action lawsuits, CellCyte Genetics Corporation (the "Company") (OTC Bulletin Board: CCYG) asserts that the pending claims are without merit and will be shown to be so in a court of law. To that end, CellCyte has retained the international law firm of Duane Morris LLP as its counsel and will defend itself vigorously in these matters. Concurrently, the Company will continue its commitment to and pursuit of its policy of ensuring that its operations comply with all applicable laws.

"CellCyte is a sound enterprise, with a solid plan to develop our technology for the delivery of adult stem cells to the human heart," said Gary A. Reys, Chairman and CEO of CellCyte. "Our highly skilled management team is committed to developing this and our other technologies to their fullest potential. We look forward to meeting these legal claims in court."

CellCyte Genetics is actively engaged in carrying out its business plan and corporate objectives as stated in the company's literature and filings. This fact is evidenced by such major advances as its move to the Company's new 26,000 foot facility and corporate offices in Bothell, Washington last month - the result of months of planning, investment and very hard work by a dedicated staff.

About CellCyte Genetics

CellCyte Genetics, a Washington State company, is an emerging biotechnology company engaged in the principal business of the discovery, development and commercialization of breakthrough stem cell enabling therapeutic products.

For further information see: http://www.cellcyte.com.

Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.

Safe Harbor Statement

THIS NEWS RELEASE CONTAINS "FORWARD-LOOKING STATEMENTS", AS THAT TERM IS DEFINED IN SECTION 27
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Hagens Berman Sobol Shapiro Announces Proposed Class-Action Lawsuit Against CellCyte
2. Hagens Berman Sobol Shapiro Investigating CellCyte
3. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
4. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
7. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
8. deCODE genetics Announces Third Quarter 2007 Financial Results
9. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
10. ZymoGenetics to Host Conference Call and Webcast on October 31, 2007 to Discuss Third Quarter Results
11. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp....lopmentAuthority(OPDA)wererecentlyawarded$2million...Board(CERB)inaprivate/publicpartnershiptoconstruct...ncolnCounty,WA. ,, "Thisinvestmentwillsignifica...r70greenjobstoLincolnCounty,"saidBlueMarbleEnergyC...
(Date:11/24/2009)... SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--Arena...ythatthecompanyisscheduledtopresentatthePiperJaffr...11:30a.m.EasternTime(8:30a.m.PacificTime)attheNewY...dent andChiefExecutiveOfficer,isscheduledtoprovide...mentanddiscoveryprograms. ,, Aliveaudiowebcasto...
(Date:11/24/2009)... SEATTLE,Nov.24/PRNewswire-FirstCall/--CellTherape...esentatthe21stAnnualPiperJaffrayHealthCareConferen...wYorkPalaceHotel. ,, CTIwillpresentonTuesday,De...liveaudiowebcastofCTI,spresentationwillbeavailable...bleforreplayafterwards. , ,PiperJaffrayHealthCare...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Amnis Corporation announced today the,release of ...ding the,Commercial release of a multilaser capabi...dramatically extending the depth of field well bey...ser upgrade provides the customer with the flexibi...05nm (violet) laser and a 658nm,(red) laser. These...
...., Aug. 23 Nektar,Therapeutics (Nasdaq: NKTR ) t...Senior Vice President and CFO. Harkness reports to...l serve as an integral member of the company,s,new...of healthcare and finance, Tim is a,critical addit... "He brings,significant experience in both financi...
...ia, Aug. 23 , Highlights -- Revenue increased 28...illion -- Excluding one-off items EBITDA increase...6 million -- Excluding one-off items NPAT increas....5 million from A$2.0 million -- Reported NPAT gr...r comparable period including one-off items -...
Other Biology Technology:Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 3Ellex FY2007 Year End Results 2Ellex FY2007 Year End Results 3
(Date:11/25/2009)...st as vital to your health as what you eat, found ...tudies. Their experiments in mice revealed that th... the liverthe body,s metabolic clearinghouseis mos...s circadian clock as conventional wisdom had it. ...large number of genes completely independent of th...
(Date:11/24/2009)...oday named 12 new grant recipients for 2009. The a... work across a broad spectrum of lupus research. A...d potential to drive scientific discovery to ultim... of systemic lupus. , The 2009 grants go to both...nation and include interdisciplinary and highly pr...
(Date:11/24/2009)...in that may help gut bacteria bind to the gastroin...otic producers to identify strains that are likely...eed to interact with cells lining the gut to have ...s in the gut they are more likely to stick around ...alie Juge from the Institute of Food Research. IF...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2One Shot May Someday Replace Six for Rabies 58126 1One Shot May Someday Replace Six for Rabies 58126 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 1University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 1Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 2Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 4Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 5Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 6
...available in French . , A novel x-ray technique... time scale never reached before has been develope...Scherrer Institute (PSI) in Switzerland. Results o...d of EPFL,s laboratory of Ultrafast Spectroscopy i... online December 11 in the journal Science . , T...
...a turtle,s first swim is the most critical of its ...ators to make it to the sea, the tiny voyager must...its bid for freedom. For youngsters hatching on th...gh: as many as 30% perish as they head for safe de...rough the waves cost the intrepid hatchlings? Curi...
...uma National Park, the last stronghold for the sav...ow hover at about 1,000 animals, down from an esti...ic weapons have decimated elephant populations pa...f the park., Civil unrest in has made conservatio...rds have been shot and killed in recent years. Ho...
Other Biology News:Molecules in the spotlight 2Cost of hatchling turtles' dash for freedom 2Missing: 2,000 elephants 2
...ulti-casting chamber is used for handcasting and v...ndcast (8.3 x 7.3 cm) or precast (8.6 x 6.8 cm) ge...udes an electrophoresis tank with built-in cooling...rculator (not included), lid with power cables, 6 ...
Protease Inhibitor Cocktail Set I from Calbiochem
...gnificantly increase the shelf life of diluted per...at room temperature storage conditions in addition...0.2 micron filtration, and contains no mercury or ... levels of activity for both the enzyme and the an...
NucleoSpin Extract II from MACHEREY-NAGEL
Biology Products: